Reference9 articles.
1. WHO classification of tumours of the haematopoeitic and lymphoid tissues;Swerdlow,2008
2. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Dreyling;Annals Oncol,2014
3. Targeting death-inducing receptors in cancer therapy;Takeda;Oncogene,2007
4. Phase 1b study of dulanermin (recombinant human Apo2L/TRAIL) in combination with paclitaxel, carboplatin, and bevacizumab in patients with advanced non-squamous non-small-cell lung cancer;Soria;J Clin Oncol,2010
5. Phase I dose-escalation study of recombi nant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer;Herbst;J Clin Oncol,2010
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献